Want to see TSE:VEXT full AI Analyst Report?
VEXT Stock Chart & Stats
C$0.32
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.32
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.15 - C$0.40
Previous CloseN/A
Volume16.50K
Average Volume (3M)40.05K
Market Cap
C$55.73M
Enterprise ValueC$75.73M
Total Cash (Recent Filing)C$5.55M
Total Debt (Recent Filing)C$34.00M
Price to Earnings (P/E)―
Beta0.59
Next Earnings
Aug 26, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding185,793,170
10 Day Avg. Volume23,955
30 Day Avg. Volume40,052
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)0.83
Price to Sales (P/S)0.88
P/FCF Ratio5.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)C$66.63M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Ohio Retail ExpansionSustained top-line acceleration driven by Ohio retail (Q1 Ohio +34% YoY) signals a structural shift to higher-margin retail channels. As company scales dispensaries and drive-thru capability, recurring store-level revenue should support durable growth and reduce reliance on volatile wholesale markets over the next 2–6 months.
Material Margin Expansion And EBITDA ImprovementMeaningful gross-margin and adjusted EBITDA improvement reflects better product mix, higher retail capture, and operational leverage. Higher margins increase internal cash generation capacity and provide a structural buffer against pricing volatility, making core profitability more durable as retail footprint scales.
Positive Operating Cash Flow And Free Cash FlowConsistent positive operating cash flow and FCF despite accounting losses indicate strong cash conversion from operations. This durable cash generation reduces reliance on external financing for store CapEx and strategic exits, supporting execution of expansion and margin initiatives over coming quarters.
Bears Say
Persistent Net Losses And Earnings VolatilityDespite recent margin gains, the company still posts large net losses and has shown profit/loss swings historically. This reduces retained-earnings capacity and increases sensitivity to adverse shocks (tax liabilities, pricing), making sustained self-funded growth and credit flexibility less reliable over the medium term.
Large Uncertain Tax Position ($10.6M)A sizable $10.6M uncertain tax position represents a material contingent liability that could require cash outflow or reserves if not resolved favorably. The lack of final rule/tax adjustments creates planning uncertainty and could materially impair liquidity or FCF if the company must settle the exposure.
Capital Intensity And Permitting Risk For Store BuildsHigh single-store CapEx and permitting/construction timing pose structural execution risk; delays increase cash burn and slow revenue ramp from new locations. This capital intensity makes expansion funding a recurring requirement and raises the chance of missed growth targets if cash generation or external financing weakens.
Vext Science News
VEXT FAQ
What was Vext Science’s price range in the past 12 months?
Vext Science lowest stock price was C$0.15 and its highest was C$0.40 in the past 12 months.
What is Vext Science’s market cap?
Vext Science’s market cap is C$55.73M.
When is Vext Science’s upcoming earnings report date?
Vext Science’s upcoming earnings report date is Aug 26, 2026 which is in 56 days.
How were Vext Science’s earnings last quarter?
Currently, no data Available
Is Vext Science overvalued?
According to Wall Street analysts Vext Science’s price is currently Overvalued.
Does Vext Science pay dividends?
Vext Science does not currently pay dividends.
What is Vext Science’s EPS estimate?
Vext Science’s EPS estimate is >-0.01.
How many shares outstanding does Vext Science have?
Vext Science has 185,793,170 shares outstanding.
What happened to Vext Science’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vext Science?
Currently, no hedge funds are holding shares in TSE:VEXT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vext Science
Vext Science, Inc., through its various subsidiaries, operates as a comprehensive agricultural technology, services, and property management company within the United States cannabis sector. Its operations span the entire product lifecycle, from cultivating and extracting to manufacturing and distributing THC and CBD vape cartridges, concentrates, and edibles. The company also manages retail dispensaries and conducts wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Expanding its edible range, Vext Science offers various THC-infused items under the Vapen Kitchens brand, including Vapen Clear products, chocolate bars, syrups, snacks, candies, and gummies. Incorporated in 2015, the company was formerly known as Vapen MJ Ventures Corporation, adopting its current name, Vext Science, Inc., in November 2019. Its headquarters are located in Phoenix, Arizona.
VEXT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated clear, measurable operational and financial improvements—strong revenue and gross-profit expansion, a notable narrowing of net loss, positive operating cash flow, and accelerating retail momentum in Ohio. Management also articulated decisive strategic action to exit low-return Arizona cultivation, reducing a material cash and margin drag. Material risks remain, including significant compression in Arizona wholesale, a ~50% drop in consolidated wholesale revenue, a $10.6M uncertain tax liability, and rising competition/price pressure in Ohio alongside capital and permitting needs. On balance, the company demonstrated that its growth and margin initiatives are working and that the negatives are being actively managed and expected to improve over the coming quarters.View all TSE:VEXT earnings summariesTechnical Analysis
Leef Brands
―
Charlotte's Web Holdings
―
MediPharm Labs
―
Planet 13 Holdings
―
Avicanna
―
Options Prices
Currently, No data available
---